Bright Minds Biosciences (DRUG) Cash & Equivalents Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 214.58% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 17.50% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -4.13% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 3.35% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 67.78% |
| 10 | Bright Minds Biosciences | 464.72 Mn | 405.19 Mn | - | 5,564.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,564.95% |
| Dec 31, 2025 | 1,351.93% |
| Sep 30, 2025 | 1,336.74% |
| Jun 30, 2025 | -16.33% |
| Mar 31, 2025 | 674.88% |
| Dec 31, 2024 | -17.39% |
| Sep 30, 2024 | -16.70% |
| Jun 30, 2024 | -43.01% |
| Mar 31, 2024 | -41.78% |
| Dec 31, 2023 | -42.14% |
| Sep 30, 2023 | -43.54% |
| Jun 30, 2023 | -44.15% |
| Mar 31, 2023 | -44.86% |
| Dec 31, 2022 | -45.36% |
| Sep 30, 2022 | -43.20% |
| Jun 30, 2022 | 2,281.60% |
| Mar 31, 2022 | 2,368.27% |
| Dec 31, 2021 | 2,454.86% |
| Sep 30, 2021 | 2,515.01% |